British National Formulary Publications

Name

British National Formulary Publications

Legal name

Pharmaceutical Press Limited

Website

https://bnf.org

Company type

Private

Founded year

1949

Operating status

Operating

Short description

British National Formulary Publications, operated by Pharmaceutical Press Limited, is a UK pharmaceutical reference publisher jointly producing the BNF and BNF for Children with BMJ Group, RCPCH, and NPPG, serving clinicians, pharmacists, hospitals, the NHS, academia, and digital health integrators globally.

Ownership category

akta.pro rank

NAICS

Book Publishers (51313)

SIC

Books: Publishing Or Publishing & Printing (2731)

akta.pro primary industry

Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

akta.pro secondary industries

Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB), Medicine & Allied Health (Clinical) (EDAGABAG)

Keywords

• Drug reference publishing
• Pharmaceutical information services
• Clinical decision support
• Medicines compendium
• Healthcare reference content

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Digital Subscription (MedicinesComplete): Online access to BNF and BNFC content through MedicinesComplete platform, available via subscription for healthcare organisations and individuals
2. Mobile App Access: BNF and BNFC apps for iOS and Android providing mobile access to medicines information
3. Print Book Sales: Sale of physical reference books including British National Formulary (BNF) 91 and BNF for Children (BNFC) 2025-2026
4. Data Licensing: Licensing BNF and BNFC content for integration into third-party clinical systems, healthcare technology platforms, and digital health applications

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

British National Formulary Publications (operating legally as Pharmaceutical Press Limited) publishes the British National Formulary (BNF) and BNF for Children (BNFC), the United Kingdom's authoritative evidence-based drug references used by healthcare professionals who prescribe, dispense, and administer medicines. Content is delivered through the MedicinesComplete digital platform, dedicated iOS and Android mobile apps, and regularly updated print editions. The company also publishes more than 20 specialist reference works covering drug interactions, palliative care, critical illness, paediatric injectables, and pharmacy law, and licenses BNF and BNFC content for integration into third-party clinical systems.

Product overview

British National Formulary Publications is a pharmaceutical knowledge publisher offering a portfolio of evidence-based reference products. The core offerings are the British National Formulary (BNF) and BNF for Children (BNFC), jointly published with BMJ Group, RCPCH, and NPPG. These are available through the MedicinesComplete online platform, a dedicated mobile app for iOS and Android, and in print editions. The portfolio extends to 20+ specialist references including Stockley's Drug Interactions, Martindale's Complete Drug Reference, Palliative Care Formulary, Critical Illness resources, drug administration guides (injectable drugs, pediatric formulations), and legal/regulatory references (MHRA guides, pharmacy law). Content licensing is available for system integration.

Differentiator

Problem solved

Functional benefit

Brands

• BNF: British National Formulary - Practical, evidence-based information for health professionals who prescribe, dispense, and administer medicines.
• BNF for Children (BNFC)

Products and services

• British National Formulary (BNF) The primary reference for concise, evidence-based medicines information used by healthcare professionals who prescribe, dispense, and administer medicines. Updated regularly and available online, as an app, and in print.
• BNF for Children (BNFC) Specialized formulary providing medicines information specifically for children, celebrating 20 years of supporting safe paediatric patient care. Jointly published by BMJ Group, Pharmaceutical Press, RCPCH, and NPPG.
• MedicinesComplete

Quantifiable outcome

• 20 years of supporting safe paediatric patient care through BNF for Children

Named customers4 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• BMJ GroupcoreStrategic or Co-development PartnerBMJ Group is a joint publisher of BNF and BNFC content alongside Pharmaceutical Press, RCPCH, and NPPG. BMJ Group provides editorial expertise and publishing infrastructure for these essential pharmaceutical reference works.
• RCPCH (Royal College of Paediatrics and Child Health)coreStrategic or Co-development PartnerRCPCH is a joint publisher of BNF for Children (BNFC), contributing paediatric expertise and clinical guidance for safe medicine use in children.
• NPPG (Neonatal and Paediatric Pharmacists Group)coreStrategic or Co-development PartnerNPPG is a joint publisher of BNF for Children (BNFC), providing specialist paediatric pharmacy knowledge and expertise.
• Pharmaceutical PresscoreStrategic or Co-development PartnerPharmaceutical Press is the publishing arm of the Royal Pharmaceutical Society and primary publisher of BNF and BNFC content through the MedicinesComplete platform.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• American Society of Health-System Pharmacists (ASHP): ASHP publishes AHFS Drug Information, ASHP Injectable Drug Information, and other drug references. Comparable as a professional-body-affiliated pharmaceutical reference publisher with overlapping injectable drug and clinical reference content (note: BNF itself distributes an ASHP title).
• epocrates (athenahealth): epocrates is a clinician-facing drug reference app used at the point of care for prescribing and interaction checks. Comparable as a mobile-first drug reference monetized via subscription and integrated into clinician workflow.
• First Databank (FDB): FDB builds drug knowledge bases (interactions, dosing, MEDS file) embedded in EHRs and pharmacy systems. Direct peer as a drug-reference data licensor to clinical systems — the same OEM/data licensing business model BNF operates.
• DynaMedex (EBSCO): DynaMedex (formerly DynaMed + Micromedex) is a point-of-care clinical decision support reference combining disease and drug content. Direct peer in clinical decision support reference content sold to hospitals and clinicians.
• IBM Micromedex: IBM Micromedex is a widely used drug and clinical reference suite (interactions, IV compatibility, neonatal/pediatric content) integrated into hospital EHRs. Direct peer to BNF on drug reference, drug interaction checking, and pediatric formulary content.

Regional players

• National Institute for Health and Care Excellence (NICE): NICE publishes UK clinical guidelines and is referenced alongside BNF for prescribing decisions in the NHS. Adjacent UK public-sector comparator — not a commercial peer, but a co-anchor of UK evidence-based prescribing workflows.

Broad incumbents

• Wolters Kluwer (UpToDate, Lexicomp, Medi-Span): Wolters Kluwer's Clinical Solutions division operates UpToDate (point-of-care clinical decision support) and Lexicomp/Medi-Span (drug reference databases). Directly comparable as a drug reference and clinical decision support publisher with broader portfolio reach.
• Elsevier (ClinicalKey, Clinical Pharmacology): Elsevier publishes Clinical Pharmacology (drug reference used by US hospitals) and ClinicalKey, a clinical decision support platform. Comparable as a global medical reference and clinical decision support incumbent with overlapping customer base.
• WebMD/Medscape: Medscape (WebMD) provides clinician-facing drug reference, interaction checkers, and clinical news used globally. Comparable as a digital drug reference distributed to clinicians, though with broader consumer health reach.

Others

• Royal Pharmaceutical Society (parent ecosystem): Pharmaceutical Press (the BNF publisher) is the publishing arm of the Royal Pharmaceutical Society. Listed as adjacent/parent ecosystem relationship — not a competitor, but the institutional parent whose professional authority underwrites BNF's brand.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pharmaceutical-press
• Instagraminstagram.com/pharmaceutical_press
• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about British National Formulary Publications